A randomised controlled trial of perineural vs intravenous dexamethasone for foot surgery
Date
2016
Authors
Dawson, R.
Mcleod, D.
Koerber, J.
Plummer, J.
Dracopoulos, G.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Anaesthesia, 2016; 71(3):285-290
Statement of Responsibility
R. L. Dawson, D. H. McLeod, J. P. Koerber, J. L. Plummer, G. C. Dracopoulos
Conference Name
Abstract
We used 20 ml ropivacaine 0.75% for ankle blocks before foot surgery in 90 participants who we allocated in equal numbers to: perineural dexamethasone 8 mg and intravenous saline 0.9%; perineural saline 0.9% and intravenous dexamethasone 8 mg; or perineural and intravenous saline 0.9%. Dexamethasone increased the median (IQR [range]) time for the return of some sensation or movement, from 14.6 (10.8-18.8 [5.5-38.0]) h with saline to 24.1 (19.3-29.3 [5.0-44.0]) h when given perineurally, p = 0.00098, and to 20.9 (18.3-27.8 [8.8-31.3]) h when given intravenously, p = 0.0067. Dexamethasone increased the median (IQR [range]) time for the return of normal neurology, from 17.6 (14.0-21.0 [9.5-40.5]) h with saline to 27.5 (22.0-36.3 [7.0-53.0]) h when given perineurally, p = 0.00016, and to 24.0 (20.5-32.3 [13.0-42.5]) h when given intravenously, p = 0.0022. Dexamethasone did not affect the rates of block success, postoperative pain scores, analgesic use, or nausea and vomiting. The route of dexamethasone administration did not alter its effects.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2015 The Association of Anaesthetists of Great Britain and Ireland